With the increasing demand of transparent clinical research, the whole pharmaceutical industry is facing a stiff challenge of managing public perception, of bias in reporting of selective clinical outcomes and publications of selective clinical studies in journals.
However, the mandatory regulations in different countries worldwide have been quite successful to ensure transparency in registering the clinical trials, and to some extent, in disclosing the clinical trials basic results.
The focus of this white paper is to describe the international and country-specific mandatory regulations to enhance the transparent reporting of trial registration and public disclosure of trial results.
- Clinical research
- Public disclosure
- Results posting
- Trials registry
Click here to download the white paper